Key Metrics
MARKET CAP
$397.29B
P/E RATIO
95.2
BETA
0.33
Less volatile
DIV YIELD
3.00%
52W HIGH
$244.81
52W LOW
$164.39
VOLATILITY
25.4%
30d annualized
Price Performance
30-DAY PRICE CHART
$223.93 → $224.69+0.34%
30 days agoToday
1-YEAR PERFORMANCE
$209.03 → $224.69+7.5%
ABBV | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
AbbVie Inc. is currently trading at $224.69, which is 8.2% below its 52-week high. With a beta of 0.33, the stock shows lower sensitivity to market movements.
RSI (14)NEUTRAL
30-DAY TRENDNEUTRAL
VOLUME4.0M(Below avg)
Frequently Asked Questions
Is ABBV a good buy right now?
AbbVie Inc. trades at 95.2x earnings. This is above market average, reflecting growth expectations. Current risk level is Medium based on 25.4% volatility.
Does ABBV pay dividends?
Yes, AbbVie Inc. offers a dividend yield of 3.00%. This translates to approximately $6.74 per share annually.
How volatile is ABBV?
With 30-day annualized volatility of 25.4% and beta of 0.33,ABBV is classified as Medium risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
MRKANALYZE →
Merck & Co.
Track ABBV Live
Add AbbVie Inc. to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:32 PM